Sara Zaknoen
CIK: 0001602225
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATYR
aTYR PHARMA INC
Director
Discretionary Trading P&L
Holdings
About Zaknoen Sara
Zaknoen Sara (SEC CIK 0001602225) files insider reports with the SEC as Director of aTYR PHARMA INC (ATYR).
Signal8 holds 2 ownership filings by Zaknoen Sara, all Form 4s, filed between May 2, 2025 and May 13, 2026. Those filings report 2 transactions, from May 1, 2025 to May 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Zaknoen Sara's filings is in SAN DIEGO, CA.
Recent filings by Zaknoen Sara
Other insiders filing for aTYR PHARMA INC (ATYR)
- Yaras Brandon, Chief Financial Officer
- SCHIMMEL PAUL, Director
- Coughlin Timothy, Director
- BENEVICH ERIC, Director
- Gross Jane A, Director
- Lucas Svetlana, Director